Fellow of The Academy of Medical Sciences, United Kingdom
Oliver D. Howes mostly deals with Psychosis, Dopamine, Neuroscience, Schizophrenia and Dopaminergic. His work carried out in the field of Psychosis brings together such families of science as Internal medicine, Dopamine receptor D2, Clinical psychology and Antipsychotic. Oliver D. Howes usually deals with Dopamine and limits it to topics linked to Neurochemical and Schizotypal personality disorder.
In his study, which falls under the umbrella issue of Neuroscience, Neuroinflammation and Central nervous system is strongly linked to Microglia. His research integrates issues of Glutamate receptor, Mania and First episode in his study of Schizophrenia. His studies in Dopaminergic integrate themes in fields like Amphetamine, Addiction and Pharmacology.
His primary scientific interests are in Psychosis, Schizophrenia, Neuroscience, Internal medicine and Dopamine. His work in Psychosis tackles topics such as Clinical psychology which are related to areas like Psychosocial. He has included themes like Positron emission tomography and Psychopharmacology in his Schizophrenia study.
In his research, Glutamatergic is intimately related to Endocrinology, which falls under the overarching field of Internal medicine. His Dopamine study frequently draws parallels with other fields, such as Neurochemical. He frequently studies issues relating to Pharmacology and Dopaminergic.
Oliver D. Howes mainly focuses on Internal medicine, Schizophrenia, Psychosis, Neuroscience and Endocrinology. His study looks at the relationship between Internal medicine and fields such as Antipsychotic, as well as how they intersect with chemical problems. Oliver D. Howes has researched Schizophrenia in several fields, including Positron emission tomography, Prefrontal cortex and Pathophysiology.
He interconnects Dopaminergic, Neuroimaging and Oncology in the investigation of issues within Psychosis. His Neuroscience research is multidisciplinary, incorporating perspectives in Receptor and Cannabinoid. His Endocrinology study incorporates themes from Anterior cingulate cortex, Postsynaptic potential, Human brain and Radioligand.
His scientific interests lie mostly in Internal medicine, Schizophrenia, Psychosis, Neuroscience and Dopamine. His Internal medicine research includes elements of Gastroenterology, Endocrinology, Coefficient of variation and Parietal lobe. As part of one scientific family, Oliver D. Howes deals mainly with the area of Schizophrenia, narrowing it down to issues related to the Hippocampus, and often Prefrontal cortex and Volume of distribution.
Oliver D. Howes combines subjects such as Neuroimaging, Oncology and Bioinformatics with his study of Psychosis. His work investigates the relationship between Neuroscience and topics such as Prodrome that intersect with problems in Stimulus. His work in Dopamine tackles topics such as Agonist which are related to areas like Trace amine, TAAR1, Serotonin, Binding potential and Neurotransmitter.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Dopamine Hypothesis of Schizophrenia: Version III—The Final Common Pathway
Oliver D. Howes;Shitij Kapur.
Schizophrenia Bulletin (2009)
The nature of dopamine dysfunction in schizophrenia and what this means for treatment
Oliver D. Howes;Joseph Kambeitz;Euitae Kim;Daniel Stahl.
Archives of General Psychiatry (2012)
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
G. M. Goodwin;P. M. Haddad;I. N. Ferrier;J. K. Aronson.
Journal of Psychopharmacology (2009)
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Oliver D Howes;Andrew J Montgomery;Marie-Claude Asselin;Robin M Murray.
Archives of General Psychiatry (2009)
Cognitive Functioning in Prodromal Psychosis: A Meta-analysis
Paolo Fusar-Poli;Giacomo Deste;Renata Smieskova;Stefano Barlati.
Archives of General Psychiatry (2012)
Schizophrenia: an integrated sociodevelopmental-cognitive model
Oliver D Howes;Oliver D Howes;Robin M Murray.
The Lancet (2014)
Glutamate and dopamine in schizophrenia: an update for the 21st century
Oliver Howes;Robert McCutcheon;James Michael Stone.
Journal of Psychopharmacology (2015)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Oliver D. Howes;Rob McCutcheon;Ofer Agid;Andrea De Bartolomeis.
American Journal of Psychiatry (2017)
The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.
Oliver D Howes;Oliver D Howes;Robert A McCutcheon;Robert A McCutcheon;Michael J Owen;Robin M Murray.
Biological Psychiatry (2017)
Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness
Marilia A. Calcia;David R. Bonsall;Peter S. Bloomfield;Sudhakar Selvaraj.
Psychopharmacology (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
King's College London
King's College London
King's College London
Brighton and Sussex Medical School
Royal Holloway University of London
King's College London
King's College London
King's College London
University of Birmingham
King's College London
Georgia Institute of Technology
University of Notre Dame
University of St Andrews
Grenoble Alpes University
Kyushu University
Autonomous University of Madrid
École Normale Supérieure
Roma Tre University
University of California, San Francisco
Northwestern University
San Antonio Military Medical Center
University of Oslo
University of London
Tokyo Medical and Dental University
Johns Hopkins University School of Medicine
University of California, Berkeley